Efficacy and safety of PCSK9 inhibitor for dyslipidemia
Not Applicable
- Conditions
- refractory dyslipidemia
- Registration Number
- JPRN-UMIN000023483
- Lead Sponsor
- Sekino Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
Doctor's decision not to register to this regimen
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DL, HDL, T-cho(Pre, 1M, 3M, 6M, 1Y, 2Y)
- Secondary Outcome Measures
Name Time Method Pre, 6M, 1Y, 2Y 1) FMD 2) carotis echo 3) ABI Pre, 3M, 6M, 1Y, 2Y 4) U-alb, U-type IV collagen 5) cystatin C, ox-LDL, Lp (a), EPA/AA, Apo A1, B, E, TG 6) Cr,eGFR 7) complications